C13H18N2O3
250.29 g/mol
APIDanger
Lacosamide
CAS175481-36-4
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Lacosamide is a compound used in pharmaceutical manufacturing, primarily as an active pharmaceutical ingredient. It is supplied as a raw material for the production of medications indicated for focal-onset seizures and primary generalized tonic-clonic seizures, administered orally or intravenously.
pharmaceutical raw material for seizure disorder medicationsactive ingredient for oral and intravenous formulations
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 175481-36-4
Related Compounds
SimilarStructure SimilarSimilarity 0.74
2-acetamido-N-benzyl-3-hydroxypropanamide
CAS171623-02-2
research compound
ReferenceSame Category
Tapentadol hydrochloride
CAS175591-09-0
pharmaceutical raw material
ReferenceSame Category
Tapentadol
CAS175591-23-8
active pharmaceutical ingredient
ReferenceSame Category
Lanatoside C
CAS17575-22-3
pharmaceutical raw material
ReferenceSame Category
Valganciclovir hydrochloride
CAS175865-59-5
pharmaceutical raw material
Safety Reference
Danger
H301Toxic if swallowed
H319Causes serious eye irritation
Identifiers
IUPAC Name
(2R)-2-acetamido-N-benzyl-3-methoxypropanamide
InChIKey
VPPJLAIAVCUEMN-GFCCVEGCSA-N
SMILES
CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1
Synonyms (38)
- LQO
- MOTPOLY
- Lacosamide (JAN/USAN/INN)
- (r)-lacosamide 1
- DEA No. 2746
- Erlosamide
- Harkoseride
- LACOSAMIDE [MART.]
- Lacosamida
- Lacosamide
- Lacosamide - Bio-X trade mark
- Lacosamide CRS
- Lacosamide Oral Solution
- Lacosamide cv
- Lacosamide racemate
- Motpoly XR
- N benzyl AcMeOPrNH2
- Vimpat
- Vimpat (TN)
- ertosamide
- harkeroside
- lacosamidum